Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Marchetti

Showing results (281-290 of 450) with videos related to

Pageof 45
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Clinical classification of BRCA1 DNA missense variants: H1686Q is a novel pathogenic mutation occurring in the ontogenetically invariant THV motif of the N-terminal BRCT domainGiuseppe Giannini, Carlo Capalbo, Laura Ottini, et al.
Endocrine|February 13, 2020
Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinomaRosa Falcone, Marialuisa Sponziello, Raffella Carletti, et al.
Endocrine|March 25, 2020
Correction to: Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinomaRosa Falcone, Marialuisa Sponziello, Raffella Carletti, et al.
Tumori|April 5, 2021
Systemic effect of radiotherapy before or after nivolumab in lung cancer: an observational, retrospective, multicenter studyMaria Bassanelli, Biagio Ricciuti, Diana Giannarelli, et al.
Breast Cancer Research and Treatment|March 3, 2007
Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer familiesAmelia Buffone, Carlo Capalbo, Enrico Ricevuto, et al.
International Journal of Molecular Sciences|May 21, 2020
Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future PerspectivesGiacomo Barchiesi, Marco Mazzotta, Eriseld Krasniqi, et al.
Cancers|August 27, 2021
Multidimensional Statistical Technique for Interpreting the Spontaneous Breakthrough Cancer Pain Phenomenon. A Secondary Analysis from the IOPS-MS StudyMarco Cascella, Anna Crispo, Gennaro Esposito, et al.
International Journal of Environmental Research and Public Health|May 31, 2020
The Exponential Phase of the Covid-19 Pandemic in Central Italy: An Integrated Care PathwayCarlo Capalbo, Antonio Aceti, Maurizio Simmaco, et al.
Cancers|January 11, 2022
A 17-Gene Expression Signature for Early Identification of Poor Prognosis in Clear Cell Renal Cell CarcinomaMaria Bassanelli, Marina Borro, Michela Roberto, et al.
Future Oncology (London, England)|December 19, 2019
Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivityAntonio Frassoldati, Laura Biganzoli, Roberto Bordonaro, et al.
Pageof 45

Showing results (281-290 of 450) with videos related to

Sort By:
Pageof 45
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Clinical classification of BRCA1 DNA missense variants: H1686Q is a novel pathogenic mutation occurring in the ontogenetically invariant THV motif of the N-terminal BRCT domainGiuseppe Giannini, Carlo Capalbo, Laura Ottini, et al.
Endocrine|February 13, 2020
Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinomaRosa Falcone, Marialuisa Sponziello, Raffella Carletti, et al.
Endocrine|March 25, 2020
Correction to: Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinomaRosa Falcone, Marialuisa Sponziello, Raffella Carletti, et al.
Tumori|April 5, 2021
Systemic effect of radiotherapy before or after nivolumab in lung cancer: an observational, retrospective, multicenter studyMaria Bassanelli, Biagio Ricciuti, Diana Giannarelli, et al.
Breast Cancer Research and Treatment|March 3, 2007
Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer familiesAmelia Buffone, Carlo Capalbo, Enrico Ricevuto, et al.
International Journal of Molecular Sciences|May 21, 2020
Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future PerspectivesGiacomo Barchiesi, Marco Mazzotta, Eriseld Krasniqi, et al.
Cancers|August 27, 2021
Multidimensional Statistical Technique for Interpreting the Spontaneous Breakthrough Cancer Pain Phenomenon. A Secondary Analysis from the IOPS-MS StudyMarco Cascella, Anna Crispo, Gennaro Esposito, et al.
International Journal of Environmental Research and Public Health|May 31, 2020
The Exponential Phase of the Covid-19 Pandemic in Central Italy: An Integrated Care PathwayCarlo Capalbo, Antonio Aceti, Maurizio Simmaco, et al.
Cancers|January 11, 2022
A 17-Gene Expression Signature for Early Identification of Poor Prognosis in Clear Cell Renal Cell CarcinomaMaria Bassanelli, Marina Borro, Michela Roberto, et al.
Future Oncology (London, England)|December 19, 2019
Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivityAntonio Frassoldati, Laura Biganzoli, Roberto Bordonaro, et al.
Pageof 45